Cost and cost-effectiveness of a real-world HCV treatment program among HIV-infected individuals in Myanmar.

Lara K MarquezAntoine ChaillonKyi Pyar SoeDerek C JohnsonJean-Marc ZossoAndrea IncertiAnne LoarecAude NguyenJosephine G WalkerNyashadzaishe MafirakurevaVincent Lo Re IiiAdriane WynnCraig McIntoshSusan M KieneStephanie BrodineRichard S GarfeinPeter VickermanNatasha K Martin

Published in: BMJ global health (2021)

Using MSF programme data, the DAA treatment programme for HCV among HIV-coinfected individuals is cost-effective in Myanmar, and even more so with updated DAA prices. A simplified treatment protocol could enhance cost-effectiveness if further rollout demonstrates it is not associated with worse treatment outcomes.

Keyphrases

hiv infected
hepatitis c virus
antiretroviral therapy
human immunodeficiency virus
clinical trial
study protocol
quality improvement
electronic health record
hiv positive
hiv aids
hiv testing
double blind